Dntox
DNTOX provides animal-free, in vitro 2D and 3D test systems to assess chemical effects on the human nervous system, focusing on developmental and adult neurotoxicity. The company offers services including cell proliferation analysis, neurite outgrowth monitoring, and transcriptomic profiling to support compound prioritization and hazard identification. Their target market includes the chemical, pharmaceutical, and cosmetic industries seeking regulatory-oriented safety assessments.
Visit websiteDusseldorf, Germany
Healthtech
Biotechnology
Life Sciences
Toxicology
Funding summary
- Total raised
- €1.5M
- Funding rounds
- 1
Investors in Dntox
Investors on record for Dntox. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Dntox?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors